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Abstract 
Background: Biliopancreatic diversion with duodenal switch (BPD‑DS) has long been considered as the bariatric 
procedure with the highest peri‑operative and long‑term complication rate. However, modern peri‑operative care, 
including laparoscopic and staged‑approach, has significantly reduced the complication rate related to this pro‑
cedure. The goal of this article is to provide an overview of the current outcomes of laparoscopic BPD‑DS in a high 
volume centre.
Methods: All patients who had a laparoscopic BPD‑DS with a hand‑sewn anastomosis performed between 2011 and 
2015 (N = 566) were reviewed. Data were obtained from our prospectively maintained electronic database and are 
reported as a Mean ± standard deviation.
Results: The mean age of the 566 patients was 41 ± 10 years, with 78 % women. Initial body mass index was 
49 ± 6 kg/m2. There was no 90‑days mortality. Hospital stay was 4.5 ± 3 days. Major 30‑days complications occurred 
in 3.0 % (n = 17) of the patients and minor complications in 2.5 % (N = 14). Excess weight loss was 81 ± 14 % at 12 m, 
88 ± 13 % at 24 m, 83 ± 14 % at 36 months. Total body weight loss (kg) was 57 ± 13 kg at 12 months, 63 ± 14 kg 
at 24 months and 61 ± 17 kg at 36 months. Hemoglobin A1C (HbA1C) dropped from 6.1 ± 1 % to 4.7 ± 0.5 % 
(p < 0.005) and the percentage of patients with an HbA1C above 6 % decreased from 38 to 1.4 % (p < 0.005). Over 
21 ± 12 months follow‑up, readmission was required in 3.5 % and reoperation in 0.5 % of the patients.
Conclusion: The current short and medium‑term complication rate of laparoscopic BPD‑DS are similar to other 
mixed bariatric procedures with excellent metabolic outcomes.
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Background
Biliopancreatic Diversion (BPD) was first described by 
Nicola Scopinaro in 1979 [1]. This technique combined 
an horizontal gastric resection with closure of the duo-
denal stump, a gastro-ileostomy and an ileo-ileostomy, to 
create a 50-cm common channel and a 250-cm alimen-
tary channel. The technique was modified to a Duodenal 
Switch procedure, based on the procedure described by 
Dr DeMeester, to treat bile gastritis in the late 80’s [2]. 
It evolved in the following years to the “modern” BPD-
DS procedure, which includes a partial gastrectomy 
performed along the greater curvature (i.e., a Sleeve Gas-
trectomy, SG), transection of the duodenum 3–4 cm dis-
tal to the pylorus, and creation of a 250  cm alimentary 
limb [3, 4]. The biliary limb is anastomosed 100 cm from 
the ileo-caecal valve, to create the common channel. 
The malabsorptive component of the procedure results 
from the separation of food from the bile and pancre-
atic juice. This results in a reduction of caloric and food 
absorption, particularly of lipids, and metabolic changes 
through modifications of incretins levels. The excellent 
long-term metabolic outcomes of the procedure have 
never really be questioned. Nevertheless, Buchwald et al. 
[5] reported that Bilio-Pancreatic Diversion represented 
only 2  % of the 344,221 bariatric surgeries performed 
worldwide in 2008. There are multiple reasons for his 
Open Access
Annals of Surgical Innovation 
and Research
*Correspondence:  laurentbiertho@gmail.com 
2 Institut Universitaire de Cardiologie et de Pneumologie de Québec, 
2725, Chemin Ste‑Foy, Quebec, QC G1V 4G5, Canada
Full list of author information is available at the end of the article
Page 2 of 5Biertho et al. Ann Surg Innov Res  (2016) 10:1 
finding, including the increased technical complex-
ity, high complication and mortality rates reported in 
the literature and increased risk of protein malnutrition 
[6, 7]. However, there has been a number of significant 
improvements in the peri-operative management of mor-
bidly obese patients since the first report of laparoscopic 
BPD-DS in 1999 [8] and exposure to this procedure has 
become of outmost importance for the management of 
failure after sleeve gastrectomy.
The goal of this study is to describe the current morbid-
ity and medium term outcomes of BPD-DS in a tertiary 
care center specialized in this technique.
Methods
All patients who had a laparoscopic BPD-DS using a 
hand-sewn anastomosis at the Quebec heart and lung 
institute, a university affiliated tertiary care center, were 
included in this study. open BPD-DS has been per-
formed since 1989 in our Institution. Indication for sur-
gery follows the standard 1991 NIH recommendations 
[9]. Laparoscopic BPD-DS was introduced in November 
2006, and we first used a mechanical stapler for the duo-
denal anastomosis (21-mm circular stapled anastomo-
sis). This technique was associated with a higher rate of 
complication (including stenosis, leak, bleeding) as was 
reported previously [10]. We transitioned to hand-sewn 
anastomosis, which has been our standard operative 
technique since 2011. All patients who were operated 
using this technique were included in this study, up to 
February 2015. Data were extracted from a prospec-
tively maintained electronic database and reviewed 
retrospectively.
Patients selection
Patient selection followed the standard NIH recom-
mendations for bariatric surgery [10]. All patients were 
assessed by a bariatric surgeon, dietician, nurse special-
ized in bariatric surgery and social worker. Patients had 
an electrocardiogram, chest X-ray, blood work, sleep 
apnea testing and consultation in pneumology. Vitamins 
or minerals supplementation were started when defi-
ciencies were discovered before the surgery. Consulta-
tion with a psychiatrist was requested when patient had 
a history of psychiatric disease. Standard pre-operative 
education specific to BPD-DS or sleeve gastrectomy was 
given to all patients. Nutritional deficiencies were treated 
before surgery according to standard supplementation 
protocols.
Surgical technique
All patients followed our routine pre-operative prepara-
tion including a low-residue diet for 2  days before sur-
gery, antibioprophylaxis (Cefazolin 2–3  g at the time of 
surgery) and thrombo-prophylaxis (standard or low-
molecular weight subcutaneous heparin). A 15-mm  Hg 
pneumo-peritoneum is first created. The greater curva-
ture of the stomach is mobilized using ultrasonic shears 
(Ace Ultrasonic, Ethicon EndoSurgery, Cincinnati, OH, 
USA). A 34–44 Fr Bougie is used for the calibration of the 
sleeve. The stomach is then transected along that Bougie 
using an articulating linear stapler-cutter (Echelon-Flex 
long 60, Ethicon EndoSurgery, Cincinnati, OH, USA), 
staring 7–8 cm from the pylorus, to create a gastric res-
ervoir, with an estimated volume of 250 cc. The duode-
num is then transected 3–4 cm from the pylorus, using 
a blue cartridge. The ileo-caecal valve is then identified 
and the small bowel is transected 250 cm proximal, using 
a white cartridge. The duodeno-ileal anastomosis is then 
created. A hand-sewn anastomosis, using two posterior 
layers and one anterior layer of absorbable sutures (3-0 
V-lock© suture). The mesenteric window is closed using 
a 2-0 Prolene suture. Routine cholecystectomy was also 
performed.
Standard post-operative orders are used, including 
ulcer prevention, thrombo-prophylaxis and feeding pro-
tocol. Patients were discharged when tolerating a soft 
diet, with vitamins and minerals daily supplementations. 
Patients received a multivitamin complex (Centrum 
Forte), vitamin A 20.000  IU, vitamin D 50.000  IU, cal-
cium carbonate 1000 mg and ferrous sulfate 300 mg.
Follow‑up
Patients were followed at the clinics at 4, 8, 12, 18 and 
24  months post-op and yearly thereafter. Blood analy-
ses were performed at these times, including a complete 
blood count, electrolytes, urea and creatinine, calcium, 
parathormone levels, vitamin D, vitamin A, serum iron, 
total iron binding capacity and ferritin. Supplements 
were adjusted over time according to these analyses 
using standardized supplementation protocols. The per-
centage of excess weight loss (EWL) was calculated as 
followed: (initial weight–current weight)/(initial weight–
ideal weight). The ideal weight was calculated by multi-
plication the square of the patient’s height in meters by 
23. The body mass index (BMI) was calculated by divid-
ing the patient’s weight in kilograms by the square of the 
height in meters.
Statistical methods
The data are reported as the mean  ±  standard devia-
tion for continuous data or as percentages for categorical 
variables. Statistical analysis was performed using a Stu-
dent’s t test for continuous variables, and the Pearson’s 
Chi square test for categorical variables, except when a 
low number of observations required Fisher’s exact test. 
p < 0.05 was considered statistically significant.
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Results
The demographic data for the 566 patients is described 
in Table 1. Initial BMI was 49 ± 6.1 kg/m2. All patients 
underwent a laparoscopic BPD-DS in our Institution, by 
four different surgeons. One patient required conver-
sion to open surgery because of difficulties getting good 
exposure and was kept in the series in an intention-to-
treat process. Post-operative complications are described 
in Table  2. Major complications occurred in 3  % of the 
patients and reoperation was required in 1.9  % of the 
patients. A leak occurred at the duodenal anastomosis in 
0.7  % of the patients (n =  4) and at the gastric level in 
0.2 % (n = 1). There was no short- or medium-term mor-
tality, during a mean 21 ± 12 months follow-up. During 
that period, readmission for a medical problem related 
to the surgery was required in 3.5  % of the population, 
and a reoperation was required in 0.5 % (Table 3), includ-
ing two patients who required a surgical revision for 
malnutrition.
Figure 1 summarizes the percentage of EWL. EWL at 
three years (n = 60) was 83 ± 14 %, which corresponds to 
a total body weight loss of 61 ± 17 kg. At that time, one 
patient (1.7 %) had a BMI above 35 kg/m2, three patients 
(5 %) had a BMI between 30 and 35 kg/m2, and 14 (23 %) 
had a BMI between 25 and 30 kg/m2.
Tables 4 and 5 summarizes some of the biological val-
ues, comparing data before to after surgery, at the time of 
last available follow-up (mean 21 ±  12  months). Before 
surgery, 38  % of the population had an Hemoglobin 
A1C (HbA1C) above 6 %. After surgery, only 1.4 % had 
an HbA1C above 6  % (p  <  0.005). There was also a sig-
nificant drop in total cholesterol, low density lipoproteins 
and triglycerides. There was a significant improvement in 
ferritin level, vitamin D-25-OH and vitamin B12. How-
ever, albumin, hemoglobin and vitamin A dropped sig-
nificantly. Even though the mean albumin level dropped 
significantly, values were below normal (35 gr/l) in only 
two patients at 2 years (2/182, 1.1 %) and one patient at 
3 years (1/70 or 1.4 %).
Discussion
The excellent long-term weight loss and correction of 
obesity-related diseases after BPD-DS have never been 
really challenged. In a meta-analysis of the bariatric lit-
erature, Buchwald et  al. [9] reported that BPD is the 
surgery offering the best long-term EWL (70.1  %) and 
improvement in type 2 diabetes (98  %). However, BPD 
has also been associated in the past, with some of the 
highest mortality rate (1.1  % compared with 0.28  % for 
Table 1 Demographic data
Data are expressed as the mean ± standard deviation for continuous data and 
as percentages for categorical data
BPD‑DS
N 566
Age (years) 41 ± 9.5
% female patients 78 %
BMI (kg/m2) 49 ± 6.1
Weight (kg) 135 ± 22
Waist diameter (cm) 129 ± 35
Hip diameter (cm) 136 ± 37
Type II diabetes % (n) 50 % (282)
Hypertension, % (n) 46 % (259)
Sleep Apnea, % (n) 60 % (342)
Dyslipidemia, % (n) 30 % (171)
Number of comorbidities 4.4 ± 1.9
Table 2 Peri-operative data
Data are expressed as the mean ± standard deviation for continuous data and 
as percentages for categorical data
BPD‑DS
N 566
Operative time 199 ± 43
Blood loss 37 ± 49
Length of stay 4.5 ± 3.2
Mortality 0
Conversion 1 (0.2 %)
Table 3 Thirty-days complications
Data are presented as a percentage (number of cases)
Variable Percentage (N) Required reoperation
Major complications (N = 566)
 Duodenal leak 0.7 (4) 0.7 (4)
 Gastric leak 0.2 (1) –
 Intra‑abdominal abscess 0.5 (3) 0.2 (1)
 Pulmonary embolism 0.2 (1) –
 Myocardial infarction 0.2 (1) –
 Other 0.4 (2) 0.2 (1)
 Obstruction 0.5 (3) 0.5 (3)
 Digestive bleeding 0.4 (2) 0.4 (2)
 Total 3.0 (17) 1.9 (11)
Minor complications
 Pneumonia 0.4 (2)
 Food intolerance 1 (6)
 Stenosis 0.2 (1)
 Atelectasis 0.2 (1)
 C Difficile colitis 0.2 (1)
 Pancreatitis 0.2 (1)
 Wound infection 0.4 (2)
 Total 2.5 (14)
Grand total 5.5 (31) 1.9 (11)
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all procedures). More recently, modern peri-operative 
care, the use of minimally invasive technique and staged 
approaches have allowed a reduction of the mortality 
rate to those observed after other bariatric surgeries [11]. 
Indeed, we observed a mortality rate of 0.1 % in a series 
of 1000 BPD-DS which included our initial cases of lapa-
roscopic BPD-DS and a significant portion of open DS 
[10]. In this series, we did not experience any mortality in 
a consecutive series of 566 patients.
In that series of patients, which included 228 laparo-
scopic cases and 772 open cases [10], the major com-
plication rate was 7.4 versus 3.0 % in the present series 
(p  =  0.0002) and the minor complication rate was 9.1 
versus 5.5  % (p =  0.01). The risk of leak using a circu-
lar-stapled anastomosis was 2.6  %, while the use of a 
hand-sewn technique allowed to reduce that risk 0.4 %, 
which is consistent with the leak rate reported in recent 
series of gastric bypasses [12]. In addition, the use of a 
hand-sewn technique has allowed to virtually eliminate 
the risk of anastomotic stenosis, which occurred in an 
average of 10  % of patients who had a circular-stapled 
anastomosis.
The limitations of this study include its retrospective 
nature. Even though data were entered prospectively 
into our database, some complications might have been 
missed. In addition, we looked at short term outcomes 
and we do not have the 5–10 year data on laparoscopic 
technique to discuss the long-term metabolic changes. 
However, we believe that the technical changes related 
Fig. 1 Percentage of excess weight loss over time. Data are reported as the Mean ± standard deviation. Numbers above the curve represents the 
number of available data at each interval
Table 4 Medium-term complications
Data are presented as a percentage (number of cases)
Variable Percentage (N) Required reoperation
Denutrition 1.8 (10) 0.4 (2)
Small bowel obstruction 0.5 (3)
Food intolerance 0.5 (3)
Gallstones 0.2 (1) 1
Other 0.5 (3)
Total 3.5 % (20) 0.5 % (3)
Table 5 Changes in some biological values over time
Variable Before surgery After surgery p
Hemoglobin A1C (%, n = 473) 6.1 ± 1 4.7 ± 0.5 <0.005
Above six (%, n) 38 % (216) 1.4 % (8)
Fasting plasma glucose 
(mmol/l, n = 236)
6.57 ± 2.1 4.7 ± 0.9 <0.005
Total cholesterol (mmol/l, 
n = 236)
4.47 ± 0.9 3.2 ± 0.6 <0.005
HDL (mmol/l, n = 235) 1.22 ± 0.29 1.22 ± 0.29 NS
LDL (mmol/l, n = 233) 2.54 ± 0.79 1.55 ± 0.49 <0.005
Triglycerides (mmol/l, 
n = 233)
1.59 ± 0.8 1.0 ± 0.4 <0.005
Total cholesterol/HDL 3.79 ± 1.0 2.8 ± 0.8 <0.005
Hemoglobin (g/l, n = 506) 135 ± 11 128.5 ± 13 <0.005
Ferritin (ng/ml, n = 477) 132 ± 153 157 ± 131 <0.005
Albumin (g/l, n = 502) 42.3 ± 2.45 39.9 ± 3.8 <0.005
Vitamin A (µmol/l, n = 394) 1.9 ± 0.45 1.53 ± 0.4 <0.005
Vitamin D‑25 (mmol/l, 
n = 443)
51.6 ± 24 94.3 ± 39 <0.005
Vitamin B12 (pmol/l, n = 479) 300 ± 120 401 ± 160 <0.005
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to the laparoscopic approach should not impact the good 
long-term outcomes we reported previously, and could 
even be beneficial in decreasing the risk of ventral hernia, 
small bowel obstruction and complications related to any 
abdominal reoperation. In addition, we did not report 
the changes in quality of life or side-effects related to the 
procedure.
Conclusion
In experienced hands, laparoscopic BPD-DS is only 
slightly more technically difficult than other bariatric 
procedures, like RYGB. The rate of major peri-operative 
complications is low, at 3  %, which is in similar ranges 
compared to other bariatric procedures. In addition, 
BPD-DS offers some of the best weight loss and cure-rate 
of obesity related diseases. It also allows a better eating 
experience, by preserving the pyloric valve and avoiding 
dumping syndrome. These long-term benefits come at 
the cost of certain gastrointestinal side effects and long-
term compliance with vitamin supplementation.
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